Literature DB >> 29980653

The sulfation code for propagation of neurodegeneration.

Masahito Yamada1, Tsuyoshi Hamaguchi2.   

Abstract

Prion-like propagation of protein aggregates is thought to be an essential feature in many neurodegenerative diseases, but the mechanisms underlying transcellular transfer of protein aggregates remain unclear. Stopschinski et al. now demonstrate that the cellular uptake of tau, Aβ, and α-synuclein aggregates mediated by heparan sulfate proteoglycans (HSPGs) varies with distinct glycosaminoglycan chain length and sulfation patterns. The results help us to understand how different protein aggregates propagate, leading to distinct neurodegenerative pathologies.
© 2018 Yamada and Hamaguchi.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29980653      PMCID: PMC6036190          DOI: 10.1074/jbc.H118.003970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

2.  Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.

Authors:  Brandon B Holmes; Sarah L DeVos; Najla Kfoury; Mei Li; Rachel Jacks; Kiran Yanamandra; Mohand O Ouidja; Frances M Brodsky; Jayne Marasa; Devika P Bagchi; Paul T Kotzbauer; Timothy M Miller; Dulce Papy-Garcia; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

3.  High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates.

Authors:  Takahiro Watanabe-Nakayama; Kenjiro Ono; Masahiro Itami; Ryoichi Takahashi; David B Teplow; Masahito Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 4.  The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.

Authors:  Lary C Walker; Juliane Schelle; Mathias Jucker
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

5.  Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy.

Authors:  Tsuyoshi Hamaguchi; Yu Taniguchi; Kenji Sakai; Tetsuyuki Kitamoto; Masaki Takao; Shigeo Murayama; Yasushi Iwasaki; Mari Yoshida; Hiroshi Shimizu; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyoshi Suzuki; Hironobu Naiki; Nobuo Sanjo; Hidehiro Mizusawa; Masahito Yamada
Journal:  Acta Neuropathol       Date:  2016-06-17       Impact factor: 17.088

6.  Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus α-synuclein and β-amyloid aggregates.

Authors:  Barbara E Stopschinski; Brandon B Holmes; Gregory M Miller; Victor A Manon; Jaime Vaquer-Alicea; William L Prueitt; Linda C Hsieh-Wilson; Marc I Diamond
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

7.  Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases.

Authors:  Yoshio Tsuboi; Katsumi Doh-Ura; Tatsuo Yamada
Journal:  Neuropathology       Date:  2009-10       Impact factor: 1.906

Review 8.  What is the evidence that tau pathology spreads through prion-like propagation?

Authors:  Amrit Mudher; Morvane Colin; Simon Dujardin; Miguel Medina; Ilse Dewachter; Seyedeh Maryam Alavi Naini; Eva-Maria Mandelkow; Eckhard Mandelkow; Luc Buée; Michel Goedert; Jean-Pierre Brion
Journal:  Acta Neuropathol Commun       Date:  2017-12-19       Impact factor: 7.801

9.  Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type.

Authors:  Elisabet Ihse; Hodaka Yamakado; Xander M van Wijk; Roger Lawrence; Jeffrey D Esko; Eliezer Masliah
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 10.  Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

Authors:  Michel Goedert; Masami Masuda-Suzukake; Benjamin Falcon
Journal:  Brain       Date:  2016-09-21       Impact factor: 13.501

  10 in total
  4 in total

Review 1.  A walk through tau therapeutic strategies.

Authors:  Santosh Jadhav; Jesus Avila; Michael Schöll; Gabor G Kovacs; Enikö Kövari; Rostislav Skrabana; Lewis D Evans; Eva Kontsekova; Barbara Malawska; Rohan de Silva; Luc Buee; Norbert Zilka
Journal:  Acta Neuropathol Commun       Date:  2019-02-15       Impact factor: 7.801

2.  Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.

Authors:  Petronela Weisová; Ondrej Cehlár; Rostislav Škrabana; Monika Žilková; Peter Filipčík; Branislav Kováčech; Michal Prčina; Ľubica Wojčiaková; Ľubica Fialová; Tomáš Smolek; Eva Kontseková; Norbert Žilka; Michal Novák
Journal:  Acta Neuropathol Commun       Date:  2019-08-07       Impact factor: 7.801

Review 3.  Advances and considerations in AD tau-targeted immunotherapy.

Authors:  Alice Bittar; Nemil Bhatt; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2019-12-10       Impact factor: 5.996

Review 4.  Dysfunctional glia: contributors to neurodegenerative disorders.

Authors:  Marta Sidoryk-Wegrzynowicz; Lidia Strużyńska
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.